Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Shenzhen Jingtai Technology Co. Ltd. maintains a patent portfolio within the Biotechnology & Pharmaceuticals technology area. The portfolio currently has 3 pending office actions distributed across 3 distinct examiners. This distribution shows that each examiner is handling exactly 1 pending matter, suggesting a broad spread of oversight within the USPTO.
Despite the involvement of multiple examiners, the prosecution is centralized within 1 distinct art unit. This indicates that while individual examiners vary, the technical focus of the applications remains consistent within a specific administrative division of the office. FREDERICK C NICOLAS is the busiest examiner currently associated with the portfolio, managing 1 pending office action.
The presence of 3 pending office actions across 1 distinct art unit suggests a focused filing strategy in the Biotechnology & Pharmaceuticals sector. Practitioners can expect a consistent examination environment even as they interact with 3 different examiners. The workload is evenly split, with the busiest examiner, FREDERICK C NICOLAS, holding 1 pending action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| §112 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NICOLAS, FREDERICK C | 1 | 81.3% | +12.7% |
| DARRIGRAND, EMILY ANN | 1 | — | — |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19006958 | POWDER BUCKET AND POWDER DISPENSING DEVICE | NICOLAS, FREDERICK C | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17427103 | DRUG VIRTUAL SCREENING SYSTEM FOR CRYSTAL COMPLEXES, AND METHOD OF USING THE SAME | DARRIGRAND, EMILY ANN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19006958 | POWDER BUCKET AND POWDER DISPENSING DEVICE | NICOLAS, FREDERICK C | — |
| Art Unit | Apps |
|---|---|
| 1686 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19006958 | POWDER BUCKET AND POWDER DISPENSING DEVICE | NICOLAS, FREDERICK C | — | §112 | Non-Final OA | — | Pending | Dec 31, 2024 |
| 17427103 | DRUG VIRTUAL SCREENING SYSTEM FOR CRYSTAL COMPLEXES, AND METHOD OF USING THE SAME | DARRIGRAND, EMILY ANN | 1686 | §101§103§112Other | Non-Final OA | — | Pending | Jul 30, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial